Global Liquid Biopsy Market Size study & Forecast, by Product and Services (Kits & Reagents, Platforms & Instruments, Services) by Circulating Biomarker (Circulating Tumor Cells, Extracellular Vesicles, Circulating Tumor DNA [ctDNA], Other Biomarkers), by Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Liver Cancer, Other Cancers), by End-user (Hospitals & Laboratories and Government & Academic Research Centers) and Regional Analysis, 2023-2030
Global Next-Generation Breast Cancer Diagnostic and Screening Market: Industry Overview
The global next-generation breast cancer diagnostic and screening market was valued at $3,137.4 million in 2022 and is anticipated to reach $9,880.1 million by 2032, …
The global humanized mouse and rat model market is projected to reach USD 338 million by 2027 from USD 237 million in 2022, at a CAGR of 7.4% during the forecast period of 2022 to 2027. Currently, immunodeficient mice engrafted with functional human cells…
Global Next Generation Cancer Diagnostic Market Size study & Forecast, by Technology ( Next-Generation Sequencing, qPCR & Multiplexing, Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR), Protein Microarrays, DNA Microarrays) by Application (Biomarker Development, CTC Analysis, Proteomic Analysis, Epigenetic Analysis, Genetic Analysis), by Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Cervical Cancer, Others), by Function(Therapeutic Monitoring, Companion Diagnostics, Prognostics, Cancer Screening, Risk Analysis) and Regional Analysis, 2022-2029
The global top 10 Medical Device Technologies market is projected to reach USD 577.5 billion by 2027
from USD 437.4 billion in 2022, at a CAGR of 5.7% during the forecast period. Globally, with the rapid growth in aging population, the incidence of a numb…
Multiplex Assays Market by Product & Service (Consumables, Instruments, Software & Services), Type (Nucleic Acid, Protein), Technology (Flow Cytometry, Luminescence), Application (R&D, Diagnosis), End User (Pharma, Hospitals) - Global Forecast to 2027
Genomics Market by Product & Service (Consumables, Instrument, System & Software), Technology (Sequencing, PCR, Microarray), Study Type (Epigenomics, Biomarker Discovery), Application (Drug Discovery, Diagnostic, Agriculture) - Global Forecast to 2028
Global Multicancer Screening Market Industry Overview
The global multicancer screening market is projected to reach $7.78 billion by 2032 from $1.90 billion in 2022, growing at a CAGR of 15.09% during the forecast period 2023-2032. The growth in the glob…
Clinical Biomarkers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027
Segmented By Product (Efficacy Biomarkers, Safety Biomarkers, Validation Biomarkers), By Services (Genomic Biomarker Service, Tissue Biomarker Service, Cell Service, Proteomics Service), By Technology (Next Generation Sequencing, Polymerase Chain Reaction, Immunohistochemistry, Enzyme-Linked Immunosorbent Assay, Others), By Clinical Area (Cancer Biomarker, Cardiac Biomarker, Neurological Biomarker, Infectious Disease Biomarker, Others), By Application (Translational Research v/s Clinical Diagnostics), By End User (Biotechnology & Pharmaceutical Companies, Diagnostic Centers, Academic & Research Institutions, Others), By company and By Region
Digital Vaccine Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F
Segmented By Device Type (Smartphone, Tablets, Others), Application (Diabetes, Infectious Diseases, Cardiovascular Diseases, Others)
Stomach Cancer Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028
Segmented by Treatment Type (Immunotherapy, Targeted Therapy, Chemotherapy, Radiation Therapy, Others), By Cancer Type (Gastric Cancer/Gastroesophageal Junction Cancer v/s Gastrointestinal Stromal Tumors), By Route of Administration (Oral v/s Injectables), By Drug Class (PD-1/PD-L1 Inhibitors, HER2 Antagonists, VEGFR2 Antagonists, Others), By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Others), By Region and Competition
Personalized Medicine Market By Product (Personalized Medicine Therapeutics, Personalized Medicine Diagnostics), By Application (Oncology, Infectious disease, Neurology or Psychiatry, Cardiovascular, Others), By End User (Hospitals and Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
Global Sanger Sequencing Service Market is expected to grow at a significant rate of around 10% during the forecast period. Sanger sequencing is a DNA sequencing method that was developed in the late 1970s and is still widely used today for a variety of a…
The Multiplex Assay market is expected to register a CAGR of approx. 7% over the period of 2022-2028. There are different types of multiplex assays, but the basic principle involves labeling each analyte with a specific probe (such as a fluorescent tag or…
The liquid biopsy in cancer diagnostic market is expected to grow at a strong CAGR of around 15% during the forecast period owing to the surge in the incidence of cancers, rising research and development activities for the development of novel liquid biop…